School of Public Health COVID-19 Research, Programs and Media
Children infected with a mild case of COVID-19 can still develop long COVID symptoms
While research has revealed that children and adults hospitalized with COVID-19 are more susceptible to developing long COVID symptoms, a new study by researchers at UTHealth Houston found that children infected with COVID-19, but not hospitalized, still experienced long COVID symptoms up to three months past infection.
The study was published in The Pediatric Infectious Disease Journal.
COVID-19 antibodies can last up to 500 days after infection
Adults infected with COVID-19 develop circulating antibodies that last for nearly 500 days, according to a new study led by researchers at UTHealth School of Public Health.
The findings were published in The Journal of Infectious Diseases.
Natural COVID-19 antibodies lasts seven months for children, according to new study
Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at UTHealth Houston.
HRSA grants $10.3 million to increase COVID-19 vaccination rates for three minority, low-income populations in Texas
A one-year, $10.3 million dollar grant from the U.S. Health Resources and Services Administration (HRSA) was awarded to increase COVID-19 vaccinations through the development and mobilization of existing community-based health and outreach workforces in the state by The University of Texas Health Science Center at Houston (UTHealth Houston).